Recombinant human platelet-derived growth factor for refractory nondiabetic ulcers: A retrospective series

Dermatologic Surgery

Volumn 28, Issue 8, 2002, Pages 755-760

  Harrison Balestra, Catherine ^a   Eaglstein, William H ^a   Falabela, Anna F ^a   Kirsner, Robert S ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PLATELET DERIVED GROWTH FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DECUBITUS; DIABETES MELLITUS; DRUG APPROVAL; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; FEMALE; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HUMAN; MALE; PRIORITY JOURNAL; SKIN ULCER; TREATMENT OUTCOME; WOUND HEALING;

ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LEG ULCER; MALE; MIDDLE AGED; PLATELET-DERIVED GROWTH FACTOR; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0036678903     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.2002.02004.x     Document Type: Article

References (18)

1. Role of growth factors in cutaneous wound healing: A review
2. Growth factors and wound healing: Part II. Role in normal and chronic wound healing
3. Cytokines and antagonists in wound healing
4. Characterization of biologic properties of wound fluid collected during early stages of wound healing
5. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury
6. Human wound fluid from acute wounds stimulates fibroblast and endothelial cell growth
7. Clinical efficacy of becaplermin (rhPDGF-BB) gel
8. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers: A phase III randomized placebo-controlled double-blind study
9. Sodium carboxymethyl-cellulose aqueous-based gel in patients with nonhealing lower extremity diabetic ulcers
10. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers
11. Becaplermin gel in the treatment of pressure ulcers: A phase II randomized, double-blind, placebo-controlled study
12. Which venous leg ulcers will heal with limb compression
13. Role of platelet-derived growth factor as an adjunct to surgery in the management of pressure ulcers
14. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers
15. Treatment of chronic ulcers in the lower extremities with topical becaplermin gel .01%: A multicenter open-label study
16. Use of topical recombinant human platelet-derived growth factor-BB (becaplermin) in healing chronic mixed arteriovenous lower extremity diabetic ulcers
17. Enhanced wound healing using topical recombinant human platelet-derived growth factor
18. Treatment of stingray injury with topical becaplermin gel